Browse and Search



Chant Series

Competition Law And Patents

Click to look inside Look inside

Competition Law And Patents

A Follow-on Innovation Perspective in the Biopharmaceutical Industry

Irina Haracoglou

Irina Haracoglou, Attorney at Law, Independent Researcher/Consultant

2008 272 pp Hardback 978 1 84720 599 5
ebook isbn 978 1 84844 011 1

Hardback £83.00 on-line price £74.70


Series: New Horizons in Competition Law and Economics series

Available as an eBook for subscribing libraries on Elgaronline.

For individuals at paper price on Google ebooks and

Other eBook partners.

‘This is an incredibly interesting book on an increasingly pertinent topic. . . the book is succinctly written and provides a comprehensive overview of EU law. . . providing a really useful analysis of the European cases concerned with the imposition of a duty to deal in relation to intellectual property. . . This book is a thoroughly enjoyable read, and perhaps because of its brevity the author retains her focus on the central issues being examined. I found it to be engaging and thought provoking.’
– Jane Nielsen, Competition and Consumer Law Journal


Further information

Using the example of research tools in biopharmaceutical research and innovation, this book examines the complexities of the relationship between two fundamental areas of law and policy – intellectual property rights and competition law. It addresses a question that is certain to become paramount in other industries also: how to strike the balance between initial and follow-on innovation so as to ensure that access to ‘essential’ research tools (or other fundamental elements to follow-on innovation) is not impeded. The book concludes by suggesting how competition law could be used to complement the patent balance.

Competition Law and Patents caters for various groups ranging from those with a general interest in competition law, patent law and/or biopharmaceuticals, to students who want to understand how competition and intellectual property work in practice (or to understand the interface between the two policies), and from practitioners and policymakers to people within the biopharmaceutical industry itself.

Full table of contents

Contents: Preface Part I: The Problem – Access as a Necessary Element of Follow-on Innovation? 1. Biopharmaceutical R&D: The Increased Importance of Cumulative Innovation and Related Concerns Part II: The Patent Balance and Working Solutions in the Patent System 2. The Patent System as a System of Balancing 3. The Patent System and Some Potential Safety Nets 4. The Right to Health as an Interpretive Principle of Patent Law Part III: Antitrust as a Complement to the Patent System 5. Unilateral Conduct, Intellectual Property Rights and Competition Law: A Systems’ Interaction 6. The Duty to Deal under Art. 82 EC Part IV: A More Innovation Sensitive Approach to the Interface of Competition Law and Patents? 7. The Duty to Deal as Applied to Address Technology Access Problems in the Biopharmaceutical Industry Bibliography Index

Bottom border

1) Choose your area:

  Competition Law
  Antitrust Law and Policy
  Intellectual Property
2) Enter your email address:

For more specific areas:
Specific Areas
Bottom border
Bookmark and Share